Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MHUAF's EV-to-FCF is ranked better than 74.04% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.71
vs MHUAF: 13.36
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Meihua International Medical Technologies Co (OTCPK:MHUAF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Meihua International Medical Technologies Co's PE Ratio (TTM) for today is calculated as:
Meihua International Medical Technologies Co's share price for today is $8.77.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Meihua International Medical Technologies Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $18.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Meihua International Medical Technologies Co EV-to-FCF Related Terms
Meihua International Medical Technologies Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co EV-to-FCF Chart
Meihua International Medical Technologies Co Annual Data
For the Medical Instruments & Supplies subindustry, Meihua International Medical Technologies Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meihua International Medical Technologies Co EV-to-FCF vs Medical Devices & Instruments Industry
Meihua International Medical Technologies Co's current Enterprise Value is $7.42 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Meihua International Medical Technologies Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $0.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co (MHUAF) has a EV-to-FCF of 13.36 as of Jul. 31, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Meihua International Medical Technologies Co and its competitors. According to the industry distribution chart, Meihua International Medical Technologies Co ranks #108 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 26%.
Is Meihua International Medical Technologies Co's EV-to-FCF too high?
Meihua International Medical Technologies Co's current EV-to-FCF is 13.36. The Medical Devices & Instruments industry median EV-to-FCF is 23.71. Meihua International Medical Technologies Co's value of 13.36 is 43.7% below this industry median. Based on the distribution chart, Meihua International Medical Technologies Co ranks #108 out of 416 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Meihua International Medical Technologies Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Meihua International Medical Technologies Co's EV-to-FCF compare to CUPR and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Meihua International Medical Technologies Co ranks #108 out of 416 companies for EV-to-FCF. This puts Meihua International Medical Technologies Co in the upper half of its industry. The industry median EV-to-FCF is 23.71. Meihua International Medical Technologies Co's value of 13.36 is 43.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.71, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meihua International Medical Technologies Co's current EV-to-FCF of 13.36 is 43.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Meihua International Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meihua International Medical Technologies Co's current EV-to-FCF is 13.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meihua International Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co (MHUAF) is currently considered Possible Value Trap. The stock's GF Value™ is $26.50, compared to a current price of $8.77 — trading 66.9% below its estimated fair value. The current EV-to-FCF is 13.36 and 43.7% below the Medical Devices & Instruments industry median of 23.71. Meihua International Medical Technologies Co's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Meihua International Medical Technologies Co (MHUAF), the current EV-to-FCF is 13.36 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Meihua International Medical Technologies Co (MHUAF) Overvalued in 2026?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co stock appears to be undervalued.
The current stock price of $8.77 is trading 66.9% below its estimated GF Value™ of $26.50.
GuruFocus considers Meihua International Medical Technologies Co to be Possible Value Trap.
Key valuation signals for MHUAF:
EV-to-FCF: 13.36
GF Value™: $26.50 vs. price of $8.77 (66.9% below fair value)
Industry Position: 43.7% below the Medical Devices & Instruments median (#108 of 416)
No single metric tells the full story. See the MHUAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
59GF Score
Get the complete analysis for MHUAF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MHUAF has been successfully added to your 
